choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Telaprevir

Telaprevir Newsletter
  • Developing orally administrable drugs to combat SARS-CoV-2 29 Mar 2021 13:32 GMT

    … allows for the production of drugs specific to Mpro that … inhibitors, derived from boceprevir and telaprevir – two antivirals effective against hepatitis … potential for development into oral drugs. These compounds were then administered … anti–SARS-CoV-2 drugs.

  • Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer 13 Jan 2021 07:00 GMT

    medicines development expert and Infectious Diseases Epidemiologist with global Biotech … and Inflammation at Regeneron Pharmaceuticals, Inc., where he … through launch, including Telaprevir for hepatitis C ( … monoclonal antibody for treatment of IL6-induced …

  • Hepatitis C virus drugs synergize with remdesivir against SARS-CoV-2 in vitro 17 Dec 2020 10:48 GMT

    … unprecedented development of a vaccine has also been successfully … It is the current FDA-approved antiviral for COVID- … that: four HCV drugs, boceprevir, narlaprevir, telaprevir, and vaniprevir strongly … use in the successful treatment of COVID-19 patients. …

  • Study Explores Potential of Hepatitis C Drugs to Treat Coronavirus 26 Nov 2020 09:10 GMT

    … for the treatment of COVID-19. These drugs inhibit viral … quickly develop pharmaceutical treatments for COVID-19 by repurposing existing drugs known … -known drug molecules for potential repurposing efforts including leupeptin, telaprevir, narlaprevir …

  • Several hepatitis C drugs can inhibit crucial protein in SARS-CoV-2 17 Nov 2020 07:59 GMT

    … develop pharmaceutical treatments for COVID-19 by repurposing existing drugs … and three FDA-approved hepatitis C protease inhibitors: telaprevir, narlaprevir … medical communities. More research, including clinical trials, is necessary to validate the drugs …

  • X-Ray Study Explores Potential of Hepatitis C Drugs to Treat COVID-19 17 Nov 2020 00:32 GMT

    pharmaceutical treatments for COVID-19 by repurposing existing drugsFDA-approved hepatitis C protease inhibitors: telaprevirmedical communities. More research, including clinical trials, is necessary to validate the drugs … Virtual Biotechnology Laboratory, …

  • New drug candidate suppresses SARS-CoV-2 replication 18 Sep 2020 00:59 GMT

    … of Glu-166. (C) Telaprevir was similarly docked into the … in the absence of a vaccine In the absence of … an effective vaccine against SARS-CoV-2, antiviral drugs will be … intravenously in hospital. “Thus, drugs that can effectively suppress coronavirus …

  • Vertex: Incivek for hepatitis C patients approved by FDA 17 Sep 2020 00:57 GMT

    Pharmaceuticals proclaimed that the U.S. FDA has approved Incivik (telaprevir … irrespective of their previous treatment. Statistics showed that … Hepatology, Weill Cornell Medical College and principal … ;7 hotline number. Doctors would be offered educational …

  • Telaprevir may help improve cure rate of patients retreated for Hepatitis... 06 Sep 2020 15:58 GMT

    treatment another chance, may benefit if the investigational drug telaprevir … is added to the usual treatment, reports … McHutchison. “Adding telaprevir to standard treatment for hepatitis C is … England Journal of Medicine.

  • Where Will Vertex Pharmaceuticals Be in 10 Years? 03 Feb 2020 06:13 GMT

    … easy to grasp how Vertex Pharmaceuticals (NASDAQ:VRTX) got to … virus (HCV) drug telaprevir, which went on to win FDA approval in 2011 … successful decade for the biotech. Image source: Getty Images. … for experimental pain drug VX-150. Chief Medical Officer and soon …

Satisfied with the content?

Continue to create your account.